In terms of bringing the players together to find out where the supply chain is in terms of production, what's coming off patent, what's going to generic, and all these things, that has to be a coordinated approach. The industry has gotten together for the very first time in this country to address this issue. Over the summer months they initiated this project, and you'll be receiving more information.
If you're on the front line giving out prescriptions and you don't have the information, how can you adequately provide a patient response plan for your patient without it?
The second point I want to raise is that the provinces and territories decide what they will cover for drug shortages through their formulary. Health Canada approves the drugs and then each jurisdiction will make the determination on whether they want that publicly covered or not. That is their responsibility within their jurisdictions.
The other side is that the provinces and territories have collaborated to deal with ways to better manage their pharmaceutical programs, by collective bulk purchases, as an example. Most jurisdictions, with the exception of two, have put in plans to deal with catastrophic drug plans, which was part of the accord, by the way. So there is progress in that work and they'll continue to do that.
In terms of moving forward, a lot of progress has been made since 2002 in this particular area.
Thank you.